Li Weng
-
- Nosocomial Infections in ICU 12
- Intensive Care Unit Cognitive Disorders 7
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 6
- Modeling and Simulation top 5%
- Epidemiology top 5%
- Sepsis Diagnosis and Treatment 28
- Pneumocystis jirovecii pneumonia detection and treatment 5
-
- Hemodynamic Monitoring and Therapy 12
-
- Respiratory Support and Mechanisms 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Co-authors
- Bin DuCharles D. GomersallJensen NgLowell LingYounsuck KohJason PhuaMoritoki EgiBabu Raja Shrestha
- Cited by
- Critical Care and Intensive Care MedicineApplied Microbiology and BiotechnologyInfectious Diseases
- Journals
- Critical Care (6 papers)Critical Care Medicine (5 papers)Annals of Intensive Care (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Weng
82 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Critical Care and Intensive Care Medicine 370
- Applied Microbiology and Biotechnology 74
- Infectious Diseases 521
- Modeling and Simulation 91
- Epidemiology 656
Countries citing papers authored by Li Weng
This map shows the geographic impact of Li Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Weng more than expected).
Fields of papers citing papers by Li Weng
This network shows the impact of papers produced by Li Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Weng. The network helps show where Li Weng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 2 | |
| 9 | National incidence and mortality of hospitalized sepsis in Chinabreakdown → | 2023 | 81 |
| 10 | 2022 | 4 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 38 | |
| 13 | 2020 | 15 | |
| 14 | 2019 | 16 | |
| 15 | 2018 | 108 | |
| 16 | 2017 | 60 | |
| 17 | 2017 | 7 | |
| 18 | 2011 | 54 | |
| 19 | Study on toxin characteristics of Clostridium difficile isolated from hospital | 2009 | 1 |
| 20 | Maternal Satisfaction and Clinical Effect of Kangaroo Mother Care in Preterm Infants:A Meta-analysis | 2008 | 2 |
About Li Weng
Li Weng is a scholar working on Critical Care and Intensive Care Medicine, Family Practice and Epidemiology, having authored 89 papers that have together received 2.3k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (28 papers), Nosocomial Infections in ICU (12 papers), Hemodynamic Monitoring and Therapy (12 papers), Respiratory Support and Mechanisms (9 papers), Intensive Care Unit Cognitive Disorders (7 papers), Antifungal resistance and susceptibility (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (370 citations), Applied Microbiology and Biotechnology (74 citations) and Infectious Diseases (521 citations). Li Weng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Bin Du, Charles D. Gomersall, Jensen Ng, Lowell Ling, Younsuck Koh, Jason Phua, Moritoki Egi, Babu Raja Shrestha, Chae‐Man Lim and Yaseen M. Arabi. Their work appears in journals such as Critical Care, Critical Care Medicine, Annals of Intensive Care, BMC Pulmonary Medicine and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.